Page last updated: 2024-08-24

aspartate-beta-hydroxamate and HIV Coinfection

aspartate-beta-hydroxamate has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grange, JM; Hamedi-Sangsari, F; Malley, SD; Vila, JR1
Hamedi-Sangsari, F; Lockhart, BP; Privat, A; Vignon, J; Vila, J1

Other Studies

2 other study(ies) available for aspartate-beta-hydroxamate and HIV Coinfection

ArticleYear
Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.
    Proceedings of the National Academy of Sciences of the United States of America, 1994, Nov-08, Volume: 91, Issue:23

    Topics: Antiviral Agents; Asparagine; Aspartic Acid; Cell Survival; Cells, Cultured; Didanosine; Drug Synergism; HIV Infections; Humans; Hydroxyurea; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Virus Replication; Zalcitabine; Zidovudine

1994
Neurotoxic effect of the anti-HIV drug D-aspartate beta-hydroxamate for rat primary neuronal cultures: attenuation by N-methyl-D-aspartate (NMDA) antagonists.
    Brain research, 1993, Dec-10, Volume: 630, Issue:1-2

    Topics: Animals; Asparagine; Cells, Cultured; Cerebral Cortex; HIV Infections; N-Methylaspartate; Neurons; Rats; Rats, Sprague-Dawley

1993